Standout Papers

Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chroni... 2016 2026 2019 2022 596
  1. Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial (2016)
    Jörge E. Cortes, Giuseppe Saglio et al. Journal of Clinical Oncology

Immediate Impact

57 standout
Sub-graph 1 of 21

Citing Papers

Principles and therapeutic applications of adaptive immunity
2024 Standout
Cancer statistics, 2024
2024 Standout
2 intermediate papers

Works of Luís Casanova being referenced

Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial
2016 Standout

Author Peers

Author Last Decade Papers Cites
Luís Casanova 122 236 615 494 305 18 1.1k
Hester H. van Boven 39 399 285 77 77 30 992
Antonio P. Vigliotti 121 352 140 207 64 23 894
DB Cines 206 177 1124 203 93 18 1.4k
Michael Cabbad 14 233 1020 447 50 17 1.3k
Kjell Bergfeldt 103 329 93 39 119 26 1.1k
Rick E. Blakesley 94 96 1092 944 59 24 1.4k
James D. Cox 400 245 167 89 50 23 1.1k
Debra Sarasohn 314 357 111 115 268 36 1.2k
G A Omura 107 196 406 109 298 18 1.1k
Gabriele Hänsgen 24 147 121 85 65 33 1.0k

All Works

Loading papers...

Rankless by CCL
2026